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In modem medicine devices or systems for transpoftation of large quantities of blood are fre-
quently used. Examples are hearVlung machines to be used during complicated heart surgery,
dialysis systems to detoxificate blood from patients suffering from kidney problerns, vessel
prostheses for replacement of diseased blood vessels, e.g. These devices have in common that
a large surface area of material interacts with blood. However, the blood material interaction is
not fully understood. This blood material interaction is called the compatibil i ty of blood with
materials. To improve the knowledge of blood compatibility, it is necessary that more integra-
tion should take place between the materials science, biomedical technology and hematology.
Laboratory evaluation of proposed blood compatible materials should take place with the use of
a series of standardized tests. These standardized tests should comprise: protein adsorption.
contact activation, activation of t l.re intrinsic coagulation, and adhesion and activation of
thrombocytes. Preferably the ín yitro tests should have a predictive value for the iri li lo behav-
iour of the materials.
In this disser-tation the development and application of tests to be usecl for the assessment of
blood material interaction are described. When in one test system differcnt blood con.rponents
can be measured, it is possible to establish relations between the test results obtained underthe
same conditions. Before going into subjects regarding newly developed tests and the applica-
tion of these test systems, various aspects of blood material interactions arc reviewed in chapter
1. These interactions include blood protein adsorption, contact activation, intrinsic coagulation
and fibrinolysis, platelet adhesion and - activation, and the role of natural inhibitors in blood.
This knowledge serves as a background for the development of in t ' i tro test methods to study
the blood material interaction and for the evaluation of heparin coated tnaterials in vivo.
In the chapters 2 till 5, two novel in vitro test methods are described to examine the bloocl
compatibility of various polymeric materials. The in lilro experiments are carried out with
standardized test plates, - incubation time and - temperature, and a multi protein system of 2570
citrated plasma obtained from healthy donors. The interaction of plasma with three commercial-
ly available polymeric materials and glass (chosen as reference material) was measured. These
materials are, high density polyethylene (HDPE), polytetrafluoroethylene (PTFE) and
polydimethylsiloxane (PDMS) which are widely used in medicine.
In chapters 2 and3, the first part of the intrinsic coagulation pathway, also known as the con-
tact system, is described. This pathway involves the generation of factor XII fragrnents ancl
kallikrein activity which can be measured by means of a simple chromogenic assay. The assay
is based on the conversion of the substrate Z-Lys-Phe-Arg-pNA.2HCl by human factor XII
fragments and kallikrein. Due to the activity of factor XII fragments and kallikrein, the -pNA
part is cleaved from the Z-Lys-Phe-Arg, which results in a yellow colour measurable by optical
instruments. To discriminate factor XIIf from kallikrein, aprotinin was added to one of twcr
complementary plasrna samples to selectively inhibit the kallikrein activity. It was concluded
that the polymeric materials, which were all characterized as hydrophobic materials, induce
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primarily activation of the kallik'ein/kinin system, whereas glass mainly promotes the intrinsic
clotting system. Within the polyrneric material group, our data show that PDMS is the most
potent activator, PTFE, an intermediate, and HDPE the weakest activator of the contact system.
The use of this new assay at the department of Chemical Engineering and Center for Bioengi-
neering of the University of Washington, Seattle, WA is described in chapter 3. At that labora-
tory this assay was used to evaluate the blood compatibility of different types polyurethanes and
glass (reference). Three custom synthesized available polyurethanes, a biomer-like 2000 Mw
polytetramethyleneoxide (PTMO) containing polyurethane, an octadecyl extended biomer-like
2000 Mw PTMO containing polyurethane and a hard segment polyurethane) were included in
this study. Also two con-rmercially available polyurethanes (Biomer@ and Pellethane@) were
screened. The commercially available polyurethanes activate the contact system significantly
more than the custom synthesized polyurethanes, although all five polyurethanes appeared to be
mild activators of the contact system compared with the glass.
In chapter 4, a new method to measure the adhesion of platelets onto materials is described.
Gelfiltrated platelets were labeled with europium ions by exposing platelets to hypotonic shock.
The hypotonic shock treated and labeled platelets were resuspended in autologous platelet poor
plasma. The adherence of the labeled platelets onto the polymeric materials; HDPE, PDMS and
PTFE, and glass, was determined by means of t ime resolved fluorometry on the europium
ions. Through this method numbels of adhering platelets as low as 106 per square centimeter
could be detected. The aggregation capacity of labeled platelets using the stimulating agents
polybrene and equine collagen was not affected which confirms that the platelet function was
well preser.ved. Moreover, after aggregation no release of label in the supematant was observ-
ed, suggesting that the label was firmly attached to the platelets after the hypotonic shock
treatment. The whole procedure of platelet isolation and labeling could be performed within
four hours rurd requircd no treatment of platelets with radiolabeled components. It is concluded
that using this labeling rnethod platelet adhesion studies can be carried out in a reproducible
way.
Finally, in chapter 5 , a number of test methods is described to assess the blood compatibility of
the polymeric materials; HDPE, PDMS and PTFE, and glass. The test methods included the
contact activation test (chapters 2 and 3), the newly developed quantitative platelet adhesion
method (chapter 4), an iodine radio-labeled fibrinogen adsorption assay, and two commercially
available enzyme immuno-assays. The latter assays were used to determine the release of
thrombin/antithrombin III complexes, and the release of thromboxane 82 from adhered and
activated platelets. The most important finding of this study was that a higher platelet adhesion
and -activation was found using the polymeric materials in comparison with glass. The poly-
meric materials also adsorbed a higher amount of f ibrinogen than glass. In contrast, these
polymeric materials induce a lower level of activation of the contact and clotting system than
glass. 'I'he thrombogenicity of polymeric rnaterials was mainly exerted by platelet binding and
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activation and theretbre localized on the material surface, whereas the thrornbogenicity of glass
was exerted by activation of the clotting systems.
The next par"t of this dissertation consists of two chapters, in which blclcld r.natefial interaction is
studied from a clinical point of view. In chapter 6, a series of seven anirnal (calve) experirnents
are descr ibed,  in  which the ef fects of  the use of  a polyurethane ventr - icu lar  ass is t  c lev ice
(HIA-VAD's) on hemostatic parametels were measured. The circulatory support with the
HIA-VAD's was carried out for one week. Also three Bioline heparin coated HIA-VAD's (a
covalentbinding type of heparin) were tested. All animals were anticoagulated with heparin
prior to irnplantation of the HIA-VAD's and systenically during the circulatory support periclt l.
During this period no substantial red blood cell t lauma could be detelmined in both gfolrps.
This indicates good mechanical  propert ies of  the HIA-VAD's.  However,  in  the coatcc l
HIA-VAD group thrombi were located in the rnid-section of the inÍ'low cannula ancl between thc
connection of the inflow cannula and the purnp housing. These thronrbi might be induced by'
traumatized coating areas caused by the surgical procedure. Adclitionally, alr-eady after 24 hours
of circulatory support a decrease in platelet numbers was measured. The nurnber of platelets in
this group recovered after l2 houls. The platelet consumption correlated with a lower ciegree of
platelet aggregation by equine adenosine diphosphate. Also the fibrin(ogen) degraclation proci-
ucts (FDP) increased immediately after irnplantation. The substantial increase of FDP was not
measured in the control group. The FDP levels remained higher in the hepar-in coatcd I IIA-VAD
group suggesting a preceding activation of the intrinsic coagulation pathway. which is furlher'
supported by rnole hepu'in consunrption. In ti ie non-coatecl HIA-VAD groLrp. after six clays of
circulatory support the platelet function also diminishecl, heparin levels ciropped, and FDP
levels increased as wel l .  However,  these ani rnals  were c l in ica l ly  heal thy af ter  severr  days of
circulatory support. The study using calves showed that henlostasis was irrpailed in btlt l i
groups after six days of circulatory support, whereas the heparin coated HIA-VAD's in calves
did not irnprove the blood cornpatibil i ty in this period of circulatory support.
The last chapter, chapter 7, describes the blood cornpatibil i ty of Duraflo II bloocl cilculatolv
support systems (an ionic binding type ofheparin, coated on the surface ofextlacorpoleal cir-
cuits) during cardiopulmonary bypass compared with the blood cornpatibil i ty of non-coated
systems. This study was carried out with humans. The contact activation rleasLrred by factor
XIIf activity in plasma tended to be lowel with the use of the Duraflo II tubing, whereas on this
tubing a higher binding of antibodies against adsorbed factor XII was measured than on the
control tubing. However, factor XIIf/Clinhibitor (CIINH) cornplex level increased to the sarne
extent in both groups. The r,-r lilr., measured thrornbin binding capacity of the tubing remainecl
high on the Duraflo II tubing whereas the thrornbin/antithl 'ombin l l l  (T/41-) cornplex levels in
the Duraflo II group increased slclwer during the first phase of cardiopulnronar-y b pass than in
the contrcll group. However, the fibrinopeptide A levels increased to the same exteut in both
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from the Duraflo II group. Moreover, thrombin activity was enhanced after release of the aortic
crossclamp which was measured in both groups. Platelet numbers tended to increase more in
the control group, likely by the interaction of platelet GpIb receptors to the Duraflo II tubing.
This was indicated by the higher amount of antibody binding against adsorbed platelet receptors
GpIb. However, the platelet activation assessed by the release of B-thromboglobulin was simi-
lar in both gÍoups. In conclusion, the advantages of Duraflo II heparin coating in this study
were mainly reduced by material independent stimuli and the retum of shed blood.
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